Olainfarm JSC, a leading Latvian pharmaceutical company and drug manufacturer, announced a rebranding to Olpha on June 19 The company's development strategy is to grow from a regional player to an international pharmaceutical company and Olpha aims to become one of the top ten pharmaceutical companies in Europe...
Read moreEvery June, with heart health in mind, “Mēness aptieka” raises important issues about cardiovascular diseases and their prevention, conducts public opinion polls and, in cooperation with doctors and the patient organisation, encourages greater use of prevention options and brings forth important topics for discussions relating to heart health.
Read moreResidents of Latvia follow the instructions of their doctors and have the tests prescribed by their GP or specialist carried out in a laboratory.
Read moreIn order to better understand the treatment processes of patients with cardiovascular diseases while providing much needed pharmaceutical care, pharmacists from “Mēness aptieka” met with specialists from the Latvian Centre of Cardiology...
Read moreThe Early Atherosclerosis and Dyslipidaemia Office has been opened in the “Aura” polyclinic of “Veselības centru apvienība” (VCA).
Read moreLatvia faces a shortage of teachers, with a critical situation emerging, particularly in natural sciences and technology (STEM).
Read moreIn order to further improve AB CITY Group's operations, Kristine Jučkoviča, Director of Strategic and Health Policy, has joined the management team, complementing the centralised management of functions within the holding company.
Read moreIn order to ensure that AS Olainfarm shareholders have the opportunity to receive fair value for their shares, the mandatory buy-back of AS Olainfarm shares is currently taking place. It is being conducted in accordance with the provisions of the Republic of Latvia’s Financial Instrument Market Law, and is being overseen by the Financial and Capital Market Commission (FCMC).
Read moreToday, 3 November, the Repharm Group’s parent company AS AB City has received permission from the Financial and Capital Market Commission (FCMC) to go ahead and make a mandatory AS Olainfarm share buy-back offer.
Read moreAS AB City has made an application to the Financial and Capital Market Commission (FCMC) to make a mandatory buy-back offer for the shares in AS Olainfarm.
Read moreOn Wednesday, August 25, the purchase of Olainfarm shares announced by AB City was completed...
Read moreToday, Olainfarm Share Buyback got another green light from Court and AB City buyback offer to shareholders can go ahead unhampered...
Read moreFrom 19 to 25 August 2021, JSC “AB City” offers to repurchase JSC “Olainfarm” shares owned by shareholders.
Read moreOlainfarm minority shareholders have sold sharesworth almost EUR 22.5 million to AB City
Read moreJSC “AB City” appreciates the efforts of the Financial and Capital Market Commission (FCMC) to protect minority shareholders of JSC “Olainfarm”, who wish to use the mandatory share repurchase bid...
Read moreJSC “Repharm” parent company JSC “AB City” has announced its readiness to continue purchasing the JSC “Olainfarm” shares owned by minority shareholders also after the end of the period of the mandatory tender offer for JSC “Olainfarm” shares, expiring on 17 August...
Read moreThe Financial and Capital Market Commission has decided to permit JSC “AB City” to make a mandatory repurchase offer for shares of JSC “Olainfarm”, because JSC “AB City”, based on the indirectly acquired ownership...
Read more“Repharm” group has informed Nasdaq Riga of an agreement with Nika Saveļjeva to acquire 7.8% of the voting rights in JSC “Olainfarm” by exercising these rights through JSC “AB City”, the mother company of JSC “Repharm”...
Read more